Hydroxyzine Pamoate Capsule
Product Images NDC 55154-2337

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Pamoate (NDC 55154-2337). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (238d1dcc 5db1 4e6f A75f 4cfcaa5b590a 01)

FDA Label Image

Image (238d1dcc 5db1 4e6f A75f 4cfcaa5b590a 02)

FDA Label Image

Bag Label (6ffb7c82 F780 4527 A7c3 E7d0f7b3b91e 00)

Bag Label (6ffb7c82 F780 4527 A7c3 E7d0f7b3b91e 00)
Hydroxyzine Pamoate Capsules, USP 25mg is a medication used for adults with usual dosage of 25mg per day to 100 mg per day. Children under 6 years of age take a 50mg dose that is divided daily while over 6 years take a 50 mg to 100 mg dose which is divided daily. The website found at www.majorpharmaceuticals.com has additional information on how to prescribe, precautions, and warnings. The product packaging comes in a tight, light-resistant container that should be stored at 20-25°C (68-77°F). This unit dose package is not child-resistant, so keep it out of reach of children. Avet Pharmaceuticals Inc and Major Pharmaceuticals distributed this product, and Cardinal Health, Dublin, OH 43017.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.